Fact CheckerSign in

NCT05266144Recruiting

Atrial Fibrillation Patients Treated With Catheter Ablation

A Prospective Cohort Study of Atrial Fibrillation Patients Treated With Catheter Ablation

Source: ClinicalTrials.gov · Last updated 3 Nov 2026

Brief summary (registry, in English)

This is a single-center prospective observational cohort study of atrial fibrillation patients treated with radiofrequency ablation.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
13 Feb 2022
Start date
4 Sept 2020
Primary completion date
1 Oct 2027
Lead sponsor
Peking Union Medical College Hospital
NCT number
NCT05266144

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 4 Sept 2020 to the primary completion date, 1 Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous radiofrequency ablation for atrial fibrillation

Other

  • Intra-atrial thrombus detected by TEE
  • Hyperthyroidism

Who the study is looking for

  • Non-valvular atrial fibrillation, including paroxysmal atrial fibrillation and persistent atrial fibrillation
  • 18-80 years old
  • The anteroposterior diameter of the left atrium is less than 50mm via TTE
  • Patient meets the intervention criteria for bilateral pulmonary vein isolation after evaluation by electrophysiological specialists
  • Patient consents to ablation treatment

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Peking Union Medical College Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.